Johnson & Johnson vs AbbVie Inc. — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
6.1
Hold
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
ABBV
72% of 32 covering analysts rate it Buy or Strong Buy.
⚠ earnings contracting 46% year-over-year.
Analyst Consensus
BUY
Target $252.42 (+9.3%)
24 analysts
BUY
Target $249.27 (+16.6%)
30 analysts
Fundamentals
JNJ
ABBV
26.7×
Trailing P/E
104.8×
18.2×
Forward P/E
13.2×
21.8%
Profit Margin
5.8%
68.0%
Gross Margin
72.0%
26.4%
ROE
—
9.9%
Revenue Growth
12.4%
-52.9%
Earnings Growth
-45.8%
0.33
Beta
—
—
Price / Book
—
$555.7B
Market Cap
$378.0B
$146 – $252
52-Week Range
$177 – $245
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.